Vir Biotechnology Inc (VIR)
Inventory turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 2,765 | 7,963 | 30,178 | 58,077 | 146,319 | 197,200 | 182,783 | 156,006 | 65,857 | 8,980 | 1,144 | 0 | 0 | -26,708 | -17,488 | |||
Inventory | US$ in thousands | — | 8,393 | 163 | -6,943 | — | — | -43,407 | — | 8,594 | 6,112 | — | 8,601 | — | — | — | — | — | — |
Inventory turnover | — | 0.95 | 185.14 | — | — | — | — | — | 7.66 | 1.47 | — | 0.00 | — | — | — |
December 31, 2023 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $2,765K ÷ $—K
= —
Unfortunately, without specific inventory turnover data provided for Vir Biotechnology Inc for any of the quarters listed, I am unable to perform a detailed analysis of the company's inventory turnover ratio. It is crucial for accurate analysis to have the inventory turnover figures to assess how efficiently the company is managing its inventory levels and converting them into sales. If you could provide the relevant inventory turnover data, I would be happy to assist you in interpreting and analyzing this key financial ratio for Vir Biotechnology Inc.
Peer comparison
Dec 31, 2023
Dec 31, 2023
Company name
Symbol
Inventory turnover
Vir Biotechnology Inc
VIR
—
Amgen Inc
AMGN
1.88
Bio-Techne Corp
TECH
3.75
Biogen Inc
BIIB
2.19
Gilead Sciences Inc
GILD
8.79
Halozyme Therapeutics Inc
HALO
3.31
Krystal Biotech Inc
KRYS
8.87
Moderna Inc
MRNA
35.39
Neurocrine Biosciences Inc
NBIX
24.26
Regenxbio Inc
RGNX
—
Repligen Corporation
RGEN
2.93